✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Analysts Turned Bearish on These 10 Stocks on Monday

Page 1 of 3

US stocks reached mid-November under pressure from the same trade that carried them to records. On November 5, the Nasdaq Composite posted its deepest one-day drop in 19 months and confirmed a correction, as chipmakers sank on fears that tougher AI regulation could follow the Democratic win in Congress, Reuters reported. That day the Dow fell 3.4%, the S&P 500 slid 4.4%, and the Nasdaq dropped 5.5%.

The weakness carried into the following week. Early on November 16, Nasdaq 100 futures were down 0.97% as AI-linked stocks came under pressure, and Reuters noted that markets were fully pricing a December rate increase after hotter-than-expected inflation data.

Rate Hike Bets Weigh on the AI Trade

By November 17, traders priced a 97.4% likelihood of a 25-basis-point Fed rate increase in December, according to CME FedWatch figures cited by Reuters. Higher borrowing costs matter most for the companies that have spent heavily on AI buildouts, and the spending itself is now under question from investors and strategists alike. Kathleen Brooks, research director at XTB, said investors want to know how long the “hyperscaler capex super cycle” will keep supporting chip sales growth.

Treasury yields have been moving sharply too: the 2-year yield fell more than 2 basis points on November 16, after its largest weekly rise in over two years the previous Friday. By the close on November 17, the S&P 500 and the Nasdaq had notched their first four-day streak of declines since September, Reuters reported. Fed speakers Christopher Waller, Beth Hammack, and John Williams were scheduled to talk that day, and the minutes of the October policy meeting were due the next day. For more on how analysts have treated the group during the slide, see our list of oversold AI stocks with more than 50% analyst upside.

Bank of America economists expect the October minutes to show a deeper policy divide than the 10-2 vote suggested, which leaves rate expectations as unsettled as sentiment toward AI. Investors who would rather look at cheaper names can start with our ranking of affordable stocks that Wall Street analysts like.

Our Methodology

To compile this list, we reviewed analyst rating downgrades and price target cuts announced on Monday, November 16, 2026. We have ranked these stocks in ascending order of their average upside potential, as of November 16.

At Insider Monkey, we are obsessed with what hedge funds do. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).

Analysts Turned Bearish on These 10 Stocks on Monday

10. Cannae Holdings (NYSE:CNNE)

Average Upside Potential: 7%

RBC Capital downgraded Cannae Holdings to Sector Perform from Outperform on November 16 and raised its price target to $18.00 from $17.00. The firm said the stock has limited upside to that target, which comes from a sum-of-the-parts valuation. RBC trimmed the value it puts on Cannae’s restaurants business and applied a slightly smaller discount for the holding company’s capitalized operating costs.

Cannae is a diversified holding company that owns operating businesses and is moving its portfolio toward sports and entertainment assets. RBC still likes that shift and the company’s plan to return capital through share repurchases. The firm said portfolio sales and buybacks could be an upside risk, but it wants more visibility on them before it turns more positive.

RBC now expects a loss per share of $0.56 for 2026, improved from its earlier estimate of $0.90, and a loss of $0.64 for 2028. Cannae released its results for the third quarter of 2026 on November 9. It also declared a regular quarterly cash dividend of $0.15 per share, payable on December 31 to holders of record on December 17.

9. Amrize (NYSE:AMRZ)

Average Upside Potential: 13%

Jefferies analyst Glynis Johnson downgraded Amrize to Underperform from Hold on November 16 and cut the price target to $35.20 from $42.80. Johnson said tough volume and cost comparisons in the first half of 2027 could push earnings estimates below consensus. The firm also noted that Amrize currently trades at 8.6 times 2028 EV/EBITDA.

Amrize is a North American building company that supplies branded building solutions, from foundations to rooftops, to professional builders. Jefferies expects higher raw material, energy, and freight costs to pressure margins. It does not expect price-cost pass-through in the Building Envelope segment to reach neutral until summer 2027, and it said a weak residential market limits how much cement prices can rise. Weakening markets also make investors cautious about earnings growth driven by capital spending, so Jefferies said the investment case leans more heavily on acquisitions.

The company reported its results for the third quarter of 2026 on October 28, with revenue up 2.2% to $3.77 billion and net income of $558 million. It updated its 2026 revenue guidance to $12.2 billion to $12.4 billion, citing continued cost inflation and elevated interest rates.

Page 1 of 3